Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 27, 2015
Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancerIbrahim Vedat Bayoglu, Ibrahim Yildiz, Umut Varol, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 18, 2015
Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancersIbrahim Vedat Bayoglu, Betul Bolat Kucukzeybek, Yuksel Kucukzeybek, et al.
Tumori|June 11, 2013
One-day DCF regimen in patients with metastatic gastric cancerAhmet Dirican, Yuksel Kucukzeybek, Mustafa Oktay Tarhan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 1, 2015
Adjuvant chemotherapy and prognostic factors in stage II colon cancer--Izmir Oncology Group StudyYuksel Kucukzeybek, Ahmet Dirican, Lutfiye Demir, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 18, 2013
Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: second line sunitinib treatment following IFN-alphaAhmet Dirican, Yuksel Kucukzeybek, Cigdem Erten, et al.
Case Reports in Oncological Medicine|July 15, 2014
Isolated liver metastasis of sacrococcygeal chordoma: case report and review of the literatureMurat Akyol, Umut Varol, Ibrahim Yildiz, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 8, 2014
Treatment of metastatic colorectal cancer with or without bevacizumab: can the neutrophil/lymphocyte ratio predict the efficiency of bevacizumab?Ahmet Dirican, Umut Varol, Yuksel Kucukzeybek, et al.
Cancer Biomarkers : Section a of Disease Markers|June 6, 2013
The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancerAhmet Dirican, Nese Ekinci, Arzu Avci, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 18, 2014
Second-line capecitabine and oxaliplatin combination for gemcitabine-resistant advanced pancreatic cancerIbrahim Vedat Bayoglu, Umut Varol, Ibrahim Yildiz, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 20, 2015
Trastuzumab-based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic Breast Cancer: an Anatolian Society of Medical Oncology StudyDogan Uncu, Ibrahim Vedat Bayoglu, Ulku Yalcintas Arslan, et al.
Pageof 4